InnoCan Pharma INNPF Stock
InnoCan Pharma Price Chart
InnoCan Pharma INNPF Financial and Trading Overview
| InnoCan Pharma stock price | 2.45 USD |
| Previous Close | 2.5 USD |
| Open | 2.6 USD |
| Bid | 2.43 USD x 50000 |
| Ask | 2.6 USD x 260000 |
| Day's Range | 2.5 - 2.6 USD |
| 52 Week Range | 2.5 - 14.26 USD |
| Volume | 200 USD |
| Avg. Volume | 42 USD |
| Market Cap | 11.25M USD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.34 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
INNPF Valuation Measures
| Enterprise Value | N/A |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 2.008032 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
InnoCan Pharma Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | -66.26% |
| S&P500 52-Week Change | 27.29% |
| 52 Week High | 14.26 USD |
| 52 Week Low | 2.5 USD |
| 50-Day Moving Average | 4.33 USD |
| 200-Day Moving Average | 7.41 USD |
INNPF Share Statistics
| Avg. Volume (3 month) | 42 USD |
| Avg. Daily Volume (10-Days) | 95 USD |
| Shares Outstanding | 4.5M |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | 22.62% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:65 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | N/A |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | 5.94 USD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | -0.25 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | N/A |
| Book Value Per Share (mrq) | 1.245 |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of InnoCan Pharma
| Country | United States |
| State | AB |
| City | Calgary |
| Address | 1015, 926 – 5 Avenue SW |
| ZIP | T2P 0N7 |
| Phone | 403-777-1519 |
| Website | https://innocanpharma.com |
| Industry | Household & Personal Products |
| Sector(s) | Consumer Defensive |
| Full Time Employees | N/A |
InnoCan Pharma Corporation operates as a pharmaceutical technology company in United States, Canada, Europe, and internationally. The company operates through two segments, Online sales and Other Operations. The company develops a cannabidiol (CBD)-loaded liposome drug delivery platform (CBD-LPT), which is in the preclinical trial phase to treat chronic pain management for human and veterinary health sectors. It also offers a pain-relieving topical composition, as well as compositions for the treatment of hemorrhoid, psoriasis of the scalp, vaginal atrophy, and diabetic symptoms. The company is also involved in development, manufacture, and marketing of cosmetic products. InnoCan Pharma Corporation was founded in 2017 and is headquartered in Calgary, Canada.
Q&A For InnoCan Pharma Stock
What is a current INNPF stock price?
InnoCan Pharma INNPF stock price today per share is 2.45 USD.
How to purchase InnoCan Pharma stock?
You can buy INNPF shares on the OTC Markets OTCQB exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for InnoCan Pharma?
The stock symbol or ticker of InnoCan Pharma is INNPF.
Which industry does the InnoCan Pharma company belong to?
The InnoCan Pharma industry is Household & Personal Products.
How many shares does InnoCan Pharma have in circulation?
The max supply of InnoCan Pharma shares is 4.5M.
What is InnoCan Pharma Price to Earnings Ratio (PE Ratio)?
InnoCan Pharma PE Ratio is now.
What was InnoCan Pharma earnings per share over the trailing 12 months (TTM)?
InnoCan Pharma EPS is -0.34 USD over the trailing 12 months.
Which sector does the InnoCan Pharma company belong to?
The InnoCan Pharma sector is Consumer Defensive.